https://orcid.org/0000-0003-1965-4242
References
- Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaçi D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013;69:729–35.
- Exarchou S, Wallman JK, Di Giuseppe D, Klingberg E, Sigurdardottir V, Wedrén S, et al. The national prevalence of clinically diagnosed psoriatic arthritis in Sweden in 2017. J Rheumatol 2023;50:781–8.
- Lebwohl MG, Kavanaugh A, Armstrong AW, Van Voorhees AS. US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey. Am J Clin Dermatol 2016;17:87–97.
- Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol 2015;73:242–8.
- Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 2015;74:1045–50.
- Kleinert S, Feuchtenberger M, Kneitz C, Tony HP. Psoriatic arthritis: clinical spectrum and diagnostic procedures. Clin Dermatol 2007;25:519–23.
- Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists. J Dermatolog Treat 2020;31:662–79.
- Deike M, Brinks R, Meller S, Schneider M, Sewerin P. Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany. RMD Open 2021;7:e001975.
- Wallman JK, Alenius GM, Klingberg E, Sigurdardottir V, Wedrén S, Exarchou S, et al. Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National patient register. Scand J Rheumatol 2023;52:374–84.
- Sundhedsstyrelsen. National klinisk retningslinje for psoriasis. 2019.
- Urruticoechea-Arana A, Benavent D, León F, Almodovar R, Belinchón I, de la Cueva P, et al. Psoriatic arthritis screening: a systematic literature review and experts’ recommendations. PLoS One 2021;16:e0248571.
- Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186–91.
- Audureau E, Roux F, Lons Danic D, Bagot M, Cantagrel A, Dernis E, et al. Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE-4 scale’. J Eur Acad Dermatol Venereol 2018;32:1950–3.
- Acquadro C, Conway K, Giroudet C, Mear I. Linguistic validation manual for health outcome assessments. MAPI Research Institute, 2012.
- Belinchón I, Queiro R, Salgado-Boquete L, López-Ferrer A, Ferran M, Coto-Segura P, et al. Linguistic and cultural adaptation to Spanish of the screening tool Psoriatic Arthritis UnclutteRed Screening Evaluation (PURE4). Actas Dermosifiliog (Engl Ed) 2020;111:655–64.
- Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005;8:94–104.